Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Theoretical mechanisms by which hyperglycemia and insulin resistance could cause cardiovascular diseases in diabetes.

× No keyword cloud information.

16 in total

1. CCN-2 is up-regulated by and mediates effects of matrix bound advanced glycated end-products in human renal mesangial cells.

Authors: Xiaoyu Wang; Susan V McLennan; Stephen M Twigg
Journal: J Cell Commun Signal Date: 2011-06-02 Impact factor: 5.782

Review 2. Endothelial dysfunction, inflammation, and insulin resistance: a focus on subjects at risk for type 2 diabetes.

Authors: A Enrique Caballero
Journal: Curr Diab Rep Date: 2004-08 Impact factor: 4.810

Review 3. Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?

Authors: Jean-Patrice Baillargeon; John E Nestler
Journal: J Clin Endocrinol Metab Date: 2005-11-01 Impact factor: 5.958

4. Arterial stiffness and hypertension status in Afro-Caribbean men.

Authors: Allison L Kuipers; Iva Miljkovic; Emma Barinas-Mitchell; Ryan Cvejkus; Clareann H Bunker; Victor W Wheeler; Joseph M Zmuda
Journal: J Hypertens Date: 2019-03 Impact factor: 4.844

5. Below the radar: advanced glycation end products that detour "around the side". Is HbA1c not an accurate enough predictor of long term progression and glycaemic control in diabetes?

Authors: Josephine M Forbes; Georgia Soldatos; Merlin C Thomas
Journal: Clin Biochem Rev Date: 2005-11

Review 6. Advanced glycation end products and vascular structure and function.

Authors: Georgia Soldatos; Mark Emmanuel Cooper
Journal: Curr Hypertens Rep Date: 2006-12 Impact factor: 5.369

Review 7. Is the present cut-point to define type 2 diabetes appropriate in Latin-Americans?

Authors: Patricio López-Jaramillo; Carlos Velandia-Carrillo; Diego Gómez-Arbeláez; Martin Aldana-Campos
Journal: World J Diabetes Date: 2014-12-15

8. Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy.

Authors: S Van Linthout; A Riad; N Dhayat; F Spillmann; J Du; S Dhayat; D Westermann; D Hilfiker-Kleiner; M Noutsias; U Laufs; H-P Schultheiss; C Tschöpe
Journal: Diabetologia Date: 2007-06-23 Impact factor: 10.122

9. Inhibition of PKC-θ preserves cardiac function and reduces fibrosis in streptozotocin-induced diabetic cardiomyopathy.

Authors: Zhao Li; Chowdhury S Abdullah; Zhu-Qiu Jin
Journal: Br J Pharmacol Date: 2014-06 Impact factor: 8.739

Review 10. Inhaled insulin for controlling blood glucose in patients with diabetes.

Authors: Bernard L Silverman; Christopher J Barnes; Barbara N Campaigne; Douglas B Muchmore
Journal: Vasc Health Risk Manag Date: 2007